Epigenetic-clock biological-age assessment and anti-aging (Epiclock)
| Date | Round | Amount |
|---|---|---|
| Aug 2024 | Series B Rhelixa, an epigenetics anti-aging startup, raised 490M JPY in Series B from Daiwa Corporate Investment, the KIRIN Health Innovation Fund and Leave a Nest Capital (incl. loans), taking cumulative funding to 1.28B JPY. | $3.2M |